Establishment of Immortalized Human Erythroid Progenitor Cell Lines Able to Produce Enucleated Red Blood Cells
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Transfusion of red blood cells (RBCs) is a standard and indispensable therapy in current clinical practice. In vitro production of RBCs offers a potential means to overcome a shortage of transfusable RBCs in some clinical situations and also to provide a source of cells free from possible infection or contamination by microorganisms. Thus, in vitro production of RBCs may become a standard procedure in the future. We previously reported the successful establishment of immortalized mouse erythroid progenitor cell lines that were able to produce mature RBCs very efficiently. Here, we have developed a reliable protocol for establishing immortalized human erythroid progenitor cell lines that are able to produce enucleated RBCs. These immortalized cell lines produce functional hemoglobin and express erythroid-specific markers, and these markers are upregulated following induction of differentiation in vitro. Most importantly, these immortalized cell lines all produce enucleated RBCs after induction of differentiation in vitro, although the efficiency of producing enucleated RBCs remains to be improved further. To the best of our knowledge, this is the first demonstration of the feasibility of using immortalized human erythroid progenitor cell lines as an ex vivo source for production of enucleated RBCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Figure 7 Gene expression profiles of the established erythroid progenitor cell lines estimated by quantitative RT-PCR analysis. Analyzed genes are indicated. FL, results with cDNA derived from human fetal liver. Relative expression was evaluated compared to that of FL. CB, cord blood. CB 6, 10 and 16, results with cDNA derived from cultured erythroid cells, i.e., CD34-positive cells in CB were induced to differentiate into mature erythroid cells for 6, 10 and 16 days, respectively, using the previously reported method [4]. B and A, Before and 2 days after induction of differentiation of HiDEP and HUDEP cells.](https://figures.cochat.ai/paper-figures/2c1a4cd9be89480c8e81cf1b067b0b83/establishment-of-immortalized-human-erythroid-progenitor-cell-lines-able-to-figure-7.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Furthermore, overexpression of CBL and CNN1 transgenes in a human erythroid progenitor model (HUDEP2 cells) individually and in combination also induced markers of erythroid differentiation (Fig. 3F–G and fig. S10C–D) (21).”
From Exploring genetic interaction manifolds constructed from rich single-cell phenotypes (2019) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 1×
“In order to test this possibility, we used a Tet-inducible expression system [18,19] to control expression of HPV16-E6/ E7 in iPS-derived hematopoietic progenitor cells and investigated whether such expression inhibited establishment of immortalized erythroid progenitor cell lines.”
MethodTranscriptional Activation by Tetracyclines in Mammalian Cells
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H. (1995) · Science · doi:10.1126/science.7792603 · Cited by 2,488 · cited 1×
“In order to test this possibility, we used a Tet-inducible expression system [18,19] to control expression of HPV16-E6/ E7 in iPS-derived hematopoietic progenitor cells and investigated whether such expression inhibited establishment of immortalized erythroid progenitor cell lines.”
MethodHuman Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene.
Robb, L., Lyons, I., Li, R., Hartley, L., Köntgen, F., Harvey, R. P., Metcalf, D., & Begley, C. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.7075 · Cited by 577 · cited 1×
“TAL1 plays essential roles in early hematopoiesis [13] and differentiation of erythroid cells and megakaryocytes [14,15].”
BackgroundDevelopmental and species-divergent globin switching are driven by BCL11A
Sankaran, V. G., Xu, J., Ragoczy, T., Ippolito, G. C., Walkley, C. R., Maika, S. D., Fujiwara, Y., Ito, M., Groudine, M., Bender, M. A., et al. (2009) · Nature · doi:10.1038/nature08243 · Cited by 379 · cited 1×
“Of note, BCL11A, a repressor of c-globin expression [25] and critical mediator of globin switching [26], was abundantly detected only in the HUDEP-2 cell line in which b-globin was up-regulated after differentiation (Figure 7).”
BackgroundMikkola, H. K. A., Klintman, J., Yang, H., Hock, H., Schlaeger, T. M., Fujiwara, Y., & Orkin, S. H. (2003) · Nature · doi:10.1038/nature01345 · Cited by 371 · cited 1×
“TAL1 plays essential roles in early hematopoiesis [13] and differentiation of erythroid cells and megakaryocytes [14,15].”
BackgroundProof of principle for transfusion of in vitro–generated red blood cells
Giarratana, M.-C., Rouard, H., Dumont, A., Kiger, L., Safeukui, I., Le Pennec, P.-Y., François, S., Trugnan, G., Peyrard, T., Marie, T., et al. (2011) · Blood · doi:10.1182/blood-2011-06-362038 · Cited by 342
KARASAWA, S., ARAKI, T., NAGAI, T., MIZUNO, H., & MIYAWAKI, A. (2004) · Biochemical Journal · doi:10.1042/bj20040321 · Cited by 342 · cited 1×
“The CSIV-TRE-RfA-UbC-KT lentiviral vector plasmid (Figure S2) contains the humanized Kusabira-Orange 1 (hKO1) fluorescent protein gene [11] and the reverse tetracycline (Tet)-controlled transcriptional transactivator (TAKARA BIO) linked by the Thosea asigna virus 2A peptide sequence under the control of human ubiquiti…”
BackgroundBiologic properties and enucleation of red blood cells from human embryonic stem cells
Lu, S.-J., Feng, Q., Park, J. S., Vida, L., Lee, B.-S., Strausbauch, M., Wettstein, P. J., Honig, G. R., & Lanza, R. (2008) · Blood · doi:10.1182/blood-2008-05-157198 · Cited by 293 · cited 1×
“in vitro [1,2,3] from hematopoietic stem/progenitor cells [4,5], embryonic stem (ES) cells [6], or induced pluripotent stem (iPS) cells [7].”
Background
Cited by
Items 101–200 of 418
Olivier, E. N., Zhang, S., Yan, Z., Suzuka, S. M., Roberts, K., Wang, K., & Bouhassira, E. E. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.05.006 · Cited by 38
Current Advances in Red Blood Cell Generation Using Stem Cells from Diverse Sources
Seo, Y., Shin, K., Kim, H. H., & Kim, H. (2019) · Stem Cells International · doi:10.1155/2019/9281329 · Cited by 35
“have generated immortal erythroid progenitors from iPSCs using a 2-step protocol [41]; briefly, they overexpressed one hematopoietic transcription factor Tal1 in iPSCs to induce erythroid differentiation more effectively then cultured cells with hematopoietic culture condition for 16 days.”
MethodChristaki, E. E., Politou, M., Antonelou, M. H., Athanasopoulos, A., Simantirakis, E., Seghatchian, J., & Vassilopoulos, G. (2018) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2018.12.015 · Cited by 37
Decoding the pathogenesis of Diamond–Blackfan anemia using single-cell RNA-seq
Wang, B., Wang, C., Wan, Y., Gao, J., Ma, Y., Zhang, Y., Tong, J., Zhang, Y., Liu, J., Chang, L.-X., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00389-z · Cited by 39
Self-citationModular UBE2H-CTLH E2-E3 complexes regulate erythroid maturation
Sherpa, D., Mueller, J., Karayel, Ö., Xu, P., Yao, Y., Chrustowicz, J., Gottemukkala, K. V., Baumann, C., Groß, A., Czarnecki, O., et al. (2022) · eLife · doi:10.7554/elife.77937 · Cited by 32
The E3 ligase adaptor molecule SPOP regulates fetal hemoglobin levels in adult erythroid cells
Lan, X., Khandros, E., Huang, P., Peslak, S. A., Bhardwaj, S. K., Grevet, J. D., Abdulmalik, O. Y., Wang, H., Keller, C. A., Giardine, B. M., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019032318 · Cited by 34
Epigenetic inactivation of ERF reactivates γ-globin expression in β-thalassemia
Bao, X., Zhang, X., Wang, L., Wang, Z., Huang, J., Zhang, Q., Ye, Y., Liu, Y., Chen, D., Zuo, Y., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.03.005 · Cited by 35
“HUDEP-2 cells were cultured as previously described.(36) To induce differentiation, we maintained cells in StemSpan SFEM supplemented with FBS”
MethodSelf-citationMyers, J., Couch, T. A., Murphy, Z. C., Malik, J. T., Getman, M. R., & Steiner, L. A. (2020) · Epigenetics & Chromatin · doi:10.1186/s13072-020-00337-9 · Cited by 31
Regulation of RNA polymerase II activity is essential for terminal erythroid maturation
Murphy, Z. C., Murphy, K. E., Myers, J., Getman, M. R., Couch, T. A., Schulz, V., Lezon-Geyda, K., Palumbo, C. D., Yan, H., Mohandas, N., et al. (2021) · Blood · doi:10.1182/blood.2020009903 · Cited by 31
Guo, X., Plank-Bazinet, J. L., Krivega, I. V., Dale, R., & Dean, A. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa736 · Cited by 32
“When HUDEP2 cells are induced to undergo erythroid differentiation, -globin (Figure 2F) and erythroid fingerprint genes that are negatively regulated by ETO2, including EPOR, SLC4A1, EPB41, ALAS2 and TAL1 are de-repressed (36,53).”
BackgroundAn erythroid-to-myeloid cell fate conversion is elicited by LSD1 inactivation
Yu, L., Myers, G., Ku, C.-J., Schneider, E., Wang, Y., Singh, S. A., Jearawiriyapaisarn, N., White, A. D., Moriguchi, T., Khoriaty, R. N., et al. (2021) · Blood · doi:10.1182/blood.2021011682 · Cited by 33
Demirci, S., Gudmundsdottir, B., Li, Q., Haro‐Mora, J. J., Nassehi, T., Drysdale, C. M., Yapundich, M., Gamer, J., Seifuddin, F., Tisdale, J. F., et al. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.04.013 · Cited by 32
“sHUDEP-2 cell numbers increased over the course of a 14-day differentiation period (Figure 1D), similar to the parental HUDEP-2 cell line as reported previously.(16) There was a 13-fold increase in cell number at day 10 and a 24-fold increase at day 14 of differentiation.”
BackgroundMethodResultInfluentialEvolution of nanobodies specific for BCL11A
Yin, M., Izadi, M., Tenglin, K., Viennet, T., Zhai, L., Zheng, G., Arthanari, H., Dassama, L. M. K., & Orkin, S. H. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2218959120 · Cited by 30
“HUDEP-2 cells (RCB4557) were obtained from Riken BioResource Research Center and cultured as reported before (56).”
MethodWang, H., Liu, Z., Li, C., Gil, S., Papayannopoulou, T., Doering, C. B., & Lieber, A. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000706 · Cited by 28
FGF-23 from erythroblasts promotes hematopoietic progenitor mobilization
Ishii, S., Suzuki, T., Wakahashi, K., Asada, N., Kawano, Y., Kawano, H., Sada, A., Minagawa, K., Nakamura, Y., Mizuno, S., et al. (2020) · Blood · doi:10.1182/blood.2020007172 · Cited by 27
Self-citationRed Blood Cell Generation by Three-Dimensional Aggregate Cultivation of Late Erythroblasts
Lee, E.-M., Han, S. Y., Choi, H. S., Chun, B.-H., Hwang, B., & Baek, E. J. (2014) · Tissue Engineering Part A · doi:10.1089/ten.tea.2014.0325 · Cited by 26
“To evaluate the oxygen-binding capacity, oxygen equilibrium curves were measured by a Hemox analyzer, Model B (TCS Scientific, New Hope, PA) according to the manufacturer’s recommendations.(9) Statistical analysis”
MethodKwon, S.-J., Kwon, O., Kim, K.-T., Go, Y.-H., Yu, S.-I., Lee, B., Miyoshi, H., Oh, E., Cho, S.-J., & Cha, H. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0703-y · Cited by 24
“CSIV-TRE-RfA-EF-KT lentiviral plasmids expressing doxycycline inducible EGFRviii was constructed using Gateway Technology with Clonase II (Invitrogen) as described previously [28].”
Self-citationCRISPR-Cas9 interrogation of a putative fetal globin repressor in human erythroid cells
Chung, J. E., Magis, W., Vu, J. T., Heo, S., Wartiovaara, K., Walters, M. C., Kurita, R., Nakamura, Y., Boffelli, D., Martin, D. I. K., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0208237 · Cited by 27
“generted deletion of the PRR or its sub-regions (23).”
BackgroundMethodInfluentialSelf-citationCongenital sideroblastic anemia model due to ALAS2 mutation is susceptible to ferroptosis
Ono, K., Fujiwara, T., Saito, K., Nishizawa, H., Takahashi, N., Suzuki, C., Ochi, T., Kato, H., Ishii, Y., Onodera, K., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-12940-9 · Cited by 36
Self-citationThe use of pluripotent stem cells to generate diagnostic tools for transfusion medicine
An, H. H., Gagne, A. L., Maguire, J. A., Pavani, G., Abdulmalik, O. Y., Gadue, P. J., French, D. L., Westhoff, C. M., & Chou, S. T. (2022) · Blood · doi:10.1182/blood.2022015883 · Cited by 25
Molecular interactions governing host-specificity of blood stage malaria parasites
Scully, E. J., Kanjee, U., & Duraisingh, M. T. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.10.006 · Cited by 24
Uchida, N., Haro‐Mora, J. J., Demirci, S., Fujita, A., Raines, L. N., Hsieh, M. M., & Tisdale, J. F. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.02.007 · Cited by 29
“Recently, a strain of immortalized erythroid cells (HUDEP-2) was reported to produce adult hemoglobin following differentiation [24]; however, it is more difficult to evaluate additional adult hemoglobin production with genetic modification.”
Moir-Meyer, G., Cheong, P. L., Olijnik, A.-A., Brown, J. M., Knight, S. J. L., King, A. J., Kurita, R., Nakamura, Y., Gibbons, R. J., Higgs, D. R., et al. (2018) · Methods and Protocols · doi:10.3390/mps1030028 · Cited by 26
“The recently published immortalised line derived from Human Umbilical Derived Erythroid Precursors and termed HUDEP-2 cells [8] offers an alternative system in which to study erythroid differentiation.”
BackgroundMethodSelf-citationTechnologies, T. M. R. C. P. O. B. S. A. E. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002451 · Cited by 23
Lim, Z. R., Vassilev, S., Leong, Y. W., Hang, J. W., Rénia, L., Malleret, B., & Oh, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189808 · Cited by 25
Li, D., Zhao, X., Zhou, S., Hu, Q., Wu, F., & Lee, H. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad468 · Cited by 28
Rh D blood group conversion using transcription activator-like effector nucleases
Kim, Y., Kim, H. O., Baek, E. J., Kurita, R., Cha, H., Nakamura, Y., & Kim, S. (2015) · Nature Communications · doi:10.1038/ncomms8451 · Cited by 27
Self-citationDalby, A., Ballester‐Beltrán, J., Lincetto, C., Mueller, A., Foad, N. S., Evans, A., Baye, J., Turro, E., Moreau, T., Tijssen, M. R., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.11.001 · Cited by 30
“, 2013) or induced pluripotent stem cells (iPSCs) (Kurita et al., 2013).”
BackgroundDevelopmental maturation of the hematopoietic system controlled by a Lin28b-let-7-Cbx2 axis
Wang, D., Tanaka-Yano, M., Meader, E., Kinney, M. A., Morris, V., da Rocha, E. L., Liu, N., Liu, T., Zhu, Q., Orkin, S. H., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110587 · Cited by 26
“Here, we define how the Lin28b/let-7 axis—a master regulator of hematopoietic maturation—integrates with PRC1 via Cbx2 to control age-specific hematopoietic output through regulation of chromatin modifications, explaining how Lin28b exerts such broad effects within the hematopoietic system as a master regulator of HSP…”
InfluentialFetal Hemoglobin Regulation in Beta-Thalassemia
Lu, H. Y., Orkin, S. H., & Sankaran, V. G. (2023) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.12.002 · Cited by 30
Rapid and Sensitive Assessment of Globin Chains for Gene and Cell Therapy of Hemoglobinopathies
Loucari, C. C., Patsali, P., van Dijk, T. B., Stephanou, C., Papasavva, P. L., Zanti, M., Kurita, R., Nakamura, Y., Christou, S., Sitarou, M., et al. (2018) · Human Gene Therapy Methods · doi:10.1089/hgtb.2017.190 · Cited by 23
“Analyzing differentiation of HUDEP-2 cells HUDEP-2 cells have been adopted by many groups as a cell line with properties similar to human adult CD34 basophilic erythroblasts, with ongoing optimization of differentiation protocols.(20,43) These cells proliferate and survive owing to doxycyclineinducible transgene expre…”
BackgroundMethodSelf-citationVanuytsel, K., Matte, T. M., Leung, A., Naing, Z. H., Morrison, T. A., Chui, D. H. K., Steinberg, M. H., & Murphy, G. J. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018020560 · Cited by 25
Ochi, T., Fujiwara, T., Ono, K., Suzuki, C., Nikaido, M., Inoue, D., Kato, H., Onodera, K., Ichikawa, S., Fukuhara, N., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-18921-2 · Cited by 26
Self-citationDefined Serum‐Free Medium for Bioreactor Culture of an Immortalized Human Erythroblast Cell Line
Lee, E., Lim, Z. R., Chen, H., Yang, B., Lam, A. T., Chen, A. K., Sivalingam, J., Reuveny, S., Loh, Y., & Oh, S. (2018) · Biotechnology Journal · doi:10.1002/biot.201700567 · Cited by 23
Cantú, I., & Philipsen, S. (2014) · Haematologica · doi:10.3324/haematol.2014.116483 · Cited by 28
“nally differentiate in vitro,(9) and hiPS cells have also been shown to possess hematopoietic potential, using methods similar to those for generating erythroid cells from hESCs.(10)”
MethodBlood-Borne Pathogens: A Canadian Blood Services Centre for Innovation Symposium
Walsh, G. M., Shih, A. W. Y., Solh, Z., Golder, M., Schubert, P., Fearon, M. A., & Sheffield, W. P. (2016) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2016.02.003 · Cited by 24
“This approach can establish immortalized human erythroid progenitor cell lines [75].”
Manufacturing blood ex vivo: a futuristic approach to deal with the supply and safety concerns
Singh, V. K., Saini, A., Tsuji, K., Sharma, P., & Chandra, R. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00026 · Cited by 27
“Cheng’s group reported in humans the differentiated erythroid cells obtained from human embryo might be used as a potential initial source for RBCs production (Huang et al., 2013; Kurita et al., 2013).”
BackgroundMethodSivalingam, J., Lam, A. T., Chen, H. Y., Yang, B., Chen, A. K.-L., Reuveny, S., Loh, Y., & Oh, S. (2016) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2015.0579 · Cited by 21
Bmi-1 Regulates Extensive Erythroid Self-Renewal
Kim, A. R., Olsen, J., England, S. J., Huang, Y.-S., Fegan, K. H., Delgadillo, L. F., McGrath, K. E., Kingsley, P. D., Waugh, R. E., & Palis, J. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.05.003 · Cited by 22
Research advances in erythrocyte regeneration sources and methods in vitro
Sun, S., Peng, Y., & Liu, J. (2018) · Cell Regeneration · doi:10.1016/j.cr.2018.10.001 · Cited by 22
Long noncoding RNA HBBP1 enhances γ-globin expression through the ETS transcription factor ELK1
Ma, S., Xi, H., Gao, X.-X., Yang, J.-M., Kurita, R., Nakamura, Y., Song, X., Chen, H., & Lu, D. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.03.051 · Cited by 18
Self-citationJeffery, N. N., Davidson, C., Peslak, S. A., Kingsley, P. D., Nakamura, Y., Palis, J., & Bulger, M. (2021) · Epigenetics & Chromatin · doi:10.1186/s13072-021-00408-5 · Cited by 21
Self-citation3′HS1 CTCF binding site in human β-globin locus regulates fetal hemoglobin expression
Himadewi, P., Wang, X. Q. D., Feng, F., Gore, H., Liu, Y., Yu, L., Liu, J., Kurita, R., Nakamura, Y., Pfeifer, G., et al. (2021) · eLife · doi:10.7554/elife.70557 · Cited by 20
“HUDEP clone 2 (HUDEP- 2) cells were cultured as previously described (Kurita et al., 2013).”
Self-citationJeong, H., Gil, N., Lee, H., Cho, S., Kim, K., Chun, K., Cho, H., & Cha, H. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25114 · Cited by 20
“We introduced the CSIV-TRE-RfA-UbC-KT vector [Kurita et al., 2013] containing the Wip1 wild type (WT) or Wip1 phosphatase dead mutant (DA) [Cha et al.”
MethodInfluentialLiu, S., Wu, M., Lancelot, M. M., Deng, J., Gao, Y., Roback, J. D., Chen, T., & Cheng, L. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.01.022 · Cited by 21
“An alternative approach that has been also investigated in recent years is to find a way to directly and extensively expand or immortalize erythroid precursors (erythroblasts) from a postnatal source of individual patients or desirable human donors, without the need of generating induced PSCs and lengthy differentiati…”
BackgroundKondo, A., Fujiwara, T., Okitsu, Y., Fukuhara, N., Onishi, Y., Nakamura, Y., Sawada, K., & Harigae, H. (2016) · International Journal of Hematology · doi:10.1007/s12185-016-1968-4 · Cited by 20
“Human induced pluripotent stem (iPS) cell-derived erythroid progenitor (HiDEP) cell lines were cultured as previously described [9, 10].”
MethodSelf-citationKurita, R., Funato, K., ABE, T. K., Watanabe, Y., Shiba, M., Tadokoro, K., Nakamura, Y., Nagai, T., & Satake, M. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.10.005 · Cited by 21
Self-citationXu, S., Liang, D., Wang, Q., Cheng, Y., Xie, D., Yang, G., Zhang, H., Feng, C., Zhao, F., Ren, W., et al. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01480-y · Cited by 38
Transcriptional silencing of fetal hemoglobin expression by NonO
Li, X., Chen, M., Liu, B., Lu, P., Lv, X., Zhao, X., Cui, S., Xu, P., Nakamura, Y., Kurita, R., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab671 · Cited by 18
“-globin gene repression, we utilized stabilized NonO knockdown HUDEP-2 cells (Human Umbilical Cord Blood-Derived Erythroid Progenitor) (30) to analyze the hemoglobin expression profile in humans.”
Self-citationBrusson, M., Chalumeau, A., Martinucci, P., Romano, O., Félix, T., Poletti, V., Scaramuzza, S., Ramadier, S., Masson, C., Ferrari, G., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.03.012 · Cited by 25
Fujiwara, T., Okamoto, K., Niikuni, R., Takahashi, K., Okitsu, Y., Fukuhara, N., Onishi, Y., Ishizawa, K., Ichinohasama, R., Nakamura, Y., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.10.050 · Cited by 19
“Human induced pluripotent stem (iPS) cell-derived erythroid progenitor (HiDEP) cell lines were cultured in StemSpan Serum-Free Expansion Medium (STEMCELL Technologies, Vancouver, BC, Canada) containing 3-U/mL erythropoietin, 1-lg/mL doxycycline (Sigma), and 1-lM dexamethasone (Sigma), as described previously [10].”
MethodSelf-citationMicroRNA‐2355‐5p regulates γ‐globin expression in human erythroid cells by inhibiting KLF6
Cheng, Y., Shang, X., Chen, D., Pang, D., Zhao, C., & Xu, X. (2020) · British Journal of Haematology · doi:10.1111/bjh.17134 · Cited by 19
“Human umbilical-cord-blood-derived erythroid progenitor-2 cell line (HUDEP-2) cells were cultured as previously described.(9) HEK-293T cells were cultured in Dulbecco’s modified Eagle medium (Gibco, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (Gibco).”
MethodPapasavva, P. L., Papaioannou, N. Y., Patsali, P., Kurita, R., Nakamura, Y., Sitarou, M., Christou, S., Kleanthous, M., & Lederer, C. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073626 · Cited by 19
“For five of them (BCL11A, KLF1, MYB, SOX6, TAL1), published gene expression data reveal differential expression between HUDEP-1 and HUDEP-2 cells [39,81].”
BackgroundSelf-citationNualkaew, T., Sii-Felice, K., Giorgi, M., McColl, B., Gouzil, J., Glaser, A., Voon, H. P. J., Tee, H. Y., Grigoriadis, G., Svasti, S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.037 · Cited by 20
“The LVb-sha2 lentiviral vector reduces a2-globin expression in b-HUDEP-2 cells The HUDEP-2 cell line recapitulates the human adult erythroid differentiation program.(24) To evaluate LVb-shRNA vectors in a sustain-”
BackgroundWang, S., Zhao, H., Zhang, H., Gao, C., Guo, X., Chen, L., Lobo, C. A., Yazdanbakhsh, K., Zhang, S., & An, X. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17263 · Cited by 16
Downes, D. J., Schweßinger, R., Hill, S., Nußbaum, L., Scott, C., Gosden, M. E., Hirschfeld, P. P., Telenius, J. M., Eijsbouts, C. Q., McGowan, S. J., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/813618 · Cited by 18
Self-citationA tetramer of BCL11A is required for stable protein production and fetal hemoglobin silencing
Zheng, G., Yin, M., Mehta, S., Chu, I.-T., Wang, S., Alshaye, A., Drainville, K., Buyanbat, A., Bienfait, F., Tenglin, K., et al. (2024) · Science · doi:10.1126/science.adp3025 · Cited by 22
Daniels, D. E., Ferguson, D. C. J., Griffiths, R. E., Trakarnsanga, K., Cogan, N. M., MacInnes, K. A., Mordue, K. E., Andrienko, T., Vicens, I. F., Jiménez, D. R., et al. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.06.002 · Cited by 20
“Viability data were not available for the BMDEP-1 lines, and reticulocyte values were not available for the other HUDEP lines, although they were reported as very low.(4) Nevertheless, the enucleation rate of BEL-C and BEL-P is lower than for our original line, BEL-A ( 26% versus 40%).”
Self-citationSEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type II
King, R., Lin, Z., Balbin-Cuesta, G., Myers, G., Friedman, A. D., Zhu, G., McGee, B. M., Saunders, T. L., Kurita, R., Nakamura, Y., et al. (2021) · Science Advances · doi:10.1126/sciadv.abj5293 · Cited by 24
“The HUDEP-2 immortalized cell line can be induced to differentiate into mature erythroid cells and is a good model of human terminal erythroid maturation (31).”
BackgroundSelf-citationlet-7 miRNAs repress HIC2 to regulate BCL11A transcription and hemoglobin switching
Huang, P., Peslak, S. A., Shehu, V., Keller, C. A., Giardine, B. M., Shi, J., Hardison, R. C., Blobel, G. A., & Khandros, E. (2024) · Blood · doi:10.1182/blood.2023023399 · Cited by 22
Morgan, R. A., Ma, F., Unti, M. J., Brown, D., Ayoub, P. G., Tam, C., Lathrop, L. E., Aleshe, B., Kurita, R., Nakamura, Y., et al. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.04.006 · Cited by 20
Self-citationBagchi, A., Nath, A., Thamodaran, V., Ijee, S., Palani, D., Rajendiran, V., Venkatesan, V., Datari, P. V. R., Pai, A. A., Arthur, N. B. J., et al. (2021) · Cells · doi:10.3390/cells10030523 · Cited by 20
“For the preparation of lentiviruses, HEK-293T cells were transfected with TRE-HEE-UbC-hKO1-rtTA (CSIV-TRE-HEE-UbC-KT) encoding HPV16E6/E7 (HEE) genes (a kind gift from Yukio Nakamura) [19] and lentiviral envelope plasmid pMD2.”
BackgroundMethodResultSelf-citationCombination of lentiviral and genome editing technologies for the treatment of sickle cell disease
Ramadier, S., Chalumeau, A., Félix, T., Othman, N., Aknoun, S., Casini, A., Maule, G., Masson, C., Cian, A. D., Frati, G., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.08.019 · Cited by 20
Cervellera, C. F., Mazziotta, C., Mauro, G. D., Iaquinta, M. R., Mazzoni, E., Torreggiani, E., Tognon, M. G., Martini, F., & Rotondo, J. C. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03367-8 · Cited by 18
“immortalization approaches The ability of the erythroid cell reprogramming, by the controlled exogenous expression of specific genes, provides a relevant alternative to genetic modifications, which directly modify cell genome (Table 2) [59, 65].”
BackgroundMethodResultInfluentialRecent advances in globin research using genome‐wide association studies and gene editing
Orkin, S. H. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13001 · Cited by 17
Trakarnsanga, K., Tipgomut, C., Metheetrairut, C., Wattanapanitch, M., Khuhapinant, A., Poldee, S., Kurita, R., Nakamura, Y., Srisawat, C., & Frayne, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-73991-4 · Cited by 17
Self-citationMingoia, M., Caria, C. A., Ye, L., Asunis, I., Marongiu, M. F., Manunza, L., Sollaino, M. C., Wang, J., Cabriolu, A., Kurita, R., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.17167 · Cited by 18
“396 ª 2020 British Society for Haematology and John Wiley & Sons Ltd British Journal of Haematology, 2021, 192, 395–404 HUDEP-2 was cultured as described in Kurita et al.21 b039-HSPCs were isolated from thalassaemia patients participating in the Thalamoss biobank study.22 HSPCs were sorted through CD34+-MACS (Miltenyi…”
MethodSelf-citationBlood donor variability is a modulatory factor for P. falciparum invasion phenotyping assays
Thiam, L. G., Nyarko, P., Kusi, K. A., Niang, M., Aniweh, Y., & Awandare, G. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-86438-1 · Cited by 16
“5 In addition, despite the progress made in generating immortalized erythroid cell-lines 34 retaining a mature phenotype, upscaling the production of these cells for universal 35 usage is challenging (20-25).”
Molecular basis of polycomb group protein-mediated fetal hemoglobin repression
Qin, K., Lan, X., Huang, P., Saari, M. S., Khandros, E., Keller, C. A., Giardine, B. M., Abdulmalik, O. Y., Shi, J., Hardison, R. C., et al. (2023) · Blood · doi:10.1182/blood.2022019578 · Cited by 25
Uchida, N., Ferrara, F., Drysdale, C. M., Yapundich, M., Gamer, J., Nassehi, T., DiNicola, J., Shibata, Y., Wielgosz, M. M., Kim, Y., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb0411 · Cited by 17
“Kurita (RIKEN Tsukuba Branch, Ibaraki, Japan) under a material transfer agreement (21).”
BackgroundMethodMolecular analysis of the erythroid phenotype of a patient with BCL11A haploinsufficiency
Wessels, M. W., Cnossen, M. H., van Dijk, T. B., Gillemans, N., Schmidt, K. L. J., van Lom, K., Vinjamur, D. S., Coyne, S. M., Kurita, R., Nakamura, Y., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003753 · Cited by 17
“We used the HUDEP1 and HUDEP2 erythroid progenitor cell lines as benchmarks for human fetal and adult erythropoiesis, respectively.(47) Our comparative analysis strongly supports the notion that BCL11A haploinsufficiency does not involve maintenance of the fetal phenotype of the erythroid compartment.”
MethodResultSelf-citationBeyond Hemoglobin: Screening for Malaria Host Factors
Egan, E. S. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.11.004 · Cited by 17
“line able to produce enucleated cells is an exciting development that may prove quite useful for future host-pathogen studies in malaria [53].”
BackgroundElucidation of the role of LMO2 in human erythroid cells
Inoue, A., Fujiwara, T., Okitsu, Y., Katsuoka, Y., Fukuhara, N., Onishi, Y., Ishizawa, K., & Harigae, H. (2013) · Experimental Hematology · doi:10.1016/j.exphem.2013.09.003 · Cited by 15
Erythroid-intrinsic activation of TLR8 impairs erythropoiesis in inherited anemia
Liang, J. Y., Wan, Y., Gao, J., Zheng, L., Wang, J., Wu, P., Li, Y., Wang, B., Wang, D., Ma, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50066-w · Cited by 19
“HuDEP2 cells were kindly provided by Professor Yukio Nakamura and cultured in StemSpan SFEM supplemented with 50ng/ml SCF, 1 µ g/ml doxorubicin, 1 µ M dexamethasone, 3 U/ml EPO, and 1% penicillin/ streptomycin in a humidi fi ed incubator at 37°C with 5% CO 2 22 .”
MethodSelf-citationPiantanida, N., Vecchia, M. L., Sculco, M., Talmon, M., Palattella, G., Kurita, R., Nakamura, Y., Ronchi, A. E., Dianzani, I., Ellis, S. R., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1045236 · Cited by 18
“These cells were obtained by transduction with a HPV16-E6/E7 expression system that is induced by doxycycline (Kurita et al., 2013).”
BackgroundInfluentialSelf-citationHEXIM1 is an essential transcription regulator during human erythropoiesis
Lv, X., Murphy, K. E., Murphy, Z. C., Getman, M. R., Rahman, N. F., Nakamura, Y., Blanc, L., Gallagher, P. G., Palis, J., Mohandas, N., et al. (2023) · Blood · doi:10.1182/blood.2022019495 · Cited by 15
Self-citationThe mouse KLF1 Nan variant impairs nuclear condensation and erythroid maturation
Cantú, I., van de Werken, H. J. G., Gillemans, N., Stadhouders, R., Heshusius, S., Maas, A., Esteghamat, F., Özgür, Z., van IJcken, W. F. J., Grosveld, F. G., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0208659 · Cited by 18
Saito, K., Fujiwara, T., Hatta, S., Morita, M., Ono, K., Suzuki, C., Fukuhara, N., Onishi, Y., Nakamura, Y., Kawamata, S., et al. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00387-18 · Cited by 16
“orthochromatic and polychromatic erythroblast stages (26), whereas human iPS cellderived erythroid progenitor (HiDEP) cells corresponded to the proerythroblast stage (27).”
BackgroundMethodSelf-citationFanis, P., Kousiappa, I., Phylactides, M., Kyrri, A. R., Hadjigavriel, M., Christou, S., Sitarou, M., & Kleanthous, M. (2019) · Human Mutation · doi:10.1002/humu.23817 · Cited by 16
“In addition, gene editing can be applied for the creation of the p.Ser323Leu KLF1 mutation in HUDEP‐2 cells to achieve the high levels of HbF. Finally, as KLF1 plays a critical role in globin switching by being involved in chromatin looping at the β‐globin locus, 4C or Hi‐”
BackgroundBCL2L1 is associated with γ-globin gene expression
Dai, Y., Mohammed, E. S. E., Perez, J. N., Wilson, C. A., Liu, L. Y., White, M. R., Farrell, J. J., Chui, D. H. K., Sebastiani, P., & Steinberg, M. H. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019032243 · Cited by 16
Chen, D., Xin, X.-X., Qian, H.-C., Yu, Z.-Y., & Shen, L. (2016) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1500295 · Cited by 15
Epigenetic interplay at the β-globin locus
Lee, W. S., McColl, B., Maksimovic, J., & Vadolas, J. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2017.01.014 · Cited by 15
“and BCL11A in a human erythroid cell line that exhibits an adult globin expression profile [132] resulted in an almost complete switch in expression from HbA to HbF expression.”
BackgroundCouch, T. A., Murphy, Z. C., Getman, M. R., Kurita, R., Nakamura, Y., & Steiner, L. A. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.04.001 · Cited by 14
Self-citationComprehensive Analysis of microRNAs in Human Adult Erythropoiesis
Nath, A., Rayabaram, J., Ijee, S., Bagchi, A., Chaudhury, A. D., Roy, D., Chambayil, K., Singh, J., Nakamura, Y., & Velayudhan, S. R. (2021) · Cells · doi:10.3390/cells10113018 · Cited by 16
“These miRNAs were knocked out using the CRISPR-cas9 method in HUDEP-2 cells [51], and their effects on cell survival, proliferation, and ability to differentiate were studied.”
MethodInfluentialSelf-citationFeldman, T. P., & Egan, E. S. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.917267 · Cited by 16
Phanthong, P., Borwornpinyo, S., Kitiyanant, N., Jearawiriyapaisarn, N., Nuntakarn, L., Saetan, J., Nualkaew, T., Sa‐ngiamsuntorn, K., Anurathapan, U., Dinnyés, A., et al. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.16-0121 · Cited by 14
Removal of promoter CpG methylation by epigenome editing reverses HBG silencing
Bell, H. W., Feng, R., Shah, M., Yao, Y., Douglas, J., Doerfler, P. A., Mayuranathan, T., O'Dea, M. F., Li, Y., Wang, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62177-z · Cited by 21
“Expression of HBG wasnormalized to the sum of HBG and HBB expression ( HBG /( HBG + HBB) ).”
InfluentialCulture and transfection: Two major bottlenecks in understanding Plasmodium vivax biology
Kumari, S., & Sinha, A. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1144453 · Cited by 12
“, 2013) or induced pluripotent stem (iPS) cells (Kurita et al., 2013).”
BackgroundPlasmodium falciparum exploits CD44 as a coreceptor for erythrocyte invasion
Baró, B., Kim, C. Y., Lin, C., Kongsomboonvech, A. K., Tétard, M., Peterson, N. A., Salinas, N. D., Tolia, N. H., & Egan, E. S. (2023) · Blood · doi:10.1182/blood.2023020831 · Cited by 15
Pandey, P., Zhang, N., Curtis, B. R., Newman, P. J., & Denomme, G. A. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16872 · Cited by 14
Pharmacologic induction of PGC ‐1α stimulates fetal haemoglobin gene expression
Sun, Y., Habara, A. H., Le, C. Q., Nguyen, N., Chen, R., Murphy, G. J., Chui, D. H. K., Steinberg, M. H., & Cui, S. (2022) · British Journal of Haematology · doi:10.1111/bjh.18042 · Cited by 14
Zhang, H., Zhou, Q., Chen, H., & Lu, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095002 · Cited by 15
“Clone deficiency is likely due to a specific characteristic of the HUDEP-2 cells, which are prone to deteriorate at extra-low cell densities [20,21].”
BackgroundMethodInfluentialElucidation of the Role of FAM210B in Mitochondrial Metabolism and Erythropoiesis
Suzuki, C., Fujiwara, T., Shima, H., Ono, K., Saito, K., Kato, H., Onodera, K., Ichikawa, S., Fukuhara, N., Onishi, Y., et al. (2022) · Molecular and Cellular Biology · doi:10.1128/mcb.00143-22 · Cited by 14
“HiDEP cells largely correspond to the proerythroblast stage (23) and, as such, phenotypic changes resulting from FAM210B depletion might be difficult to detect (Fig.”
BackgroundMethodInfluentialSelf-citationPark, K., Ahn, J., Kim, J. Y., Park, H., Kim, H. O., & Lee, S. (2013) · Tissue Engineering Part A · doi:10.1089/ten.tea.2013.0193 · Cited by 14
“18 The gas phase gradients were obtained using nitrogen and room air, and the curves were run in both directions.”
Detzner, J., Pohlentz, G., & Müthing, J. (2020) · Toxins · doi:10.3390/toxins12060373 · Cited by 15
Buduo, C. A. D., Aguilar, A., Soprano, P. M., Bocconi, A., Miguel, C. P., Mantica, G., & Balduini, A. (2021) · Haematologica · doi:10.3324/haematol.2020.262485 · Cited by 14
Morimoto, Y., Chonabayashi, K., Kawabata, H., Okubo, C., Morita, M., Nishikawa, M., Narita, M., Inagaki, A., Nakanishi, K., Nagao, M., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021005664 · Cited by 12
“16,18,25”
Bieker, J. J., & Philipsen, S. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-62731-6_10 · Cited by 18
Transcriptional Repressor BCL11A in Erythroid Cells
Zheng, G., & Orkin, S. H. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-62731-6_9 · Cited by 15
Metadata
- Authors
- Kurita, R., Suda, N., Sudo, K., Miharada, K., Hiroyama, T., Miyoshi, H., Tani, K., & Nakamura, Y.
- Affiliations
- RIKEN BioResource Research Center (JP)
- Kyushu University (JP)
- Corresponding author
- Nakamura, Yukio
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-03-22
- Volume
- 8
- Issue
- 3
- Pages
- e59890
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3606290
- OpenAlex
- W1974742081
- Cited by
- 418
- References
- 28
- Citations by year
- 2026: 38 · 2025: 43 · 2024: 34 · 2023: 36 · 2022: 35 · 2021: 48 · 2020: 45 · 2019: 31 · 2018: 32 · 2017: 24 · 2016: 25 · 2015: 10 · 2014: 8 · 2013: 8
- FWCI
- 12.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- RIKEN
- RIKEN Brain Science Institute
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- erythroid progenitor cells, immortalized cell lines, in vitro erythropoiesis, blood transfusion, erythroid differentiation
- MeSH terms
- Cell Nucleus, Erythrocytes, Erythropoiesis, Humans, Erythroid Precursor Cells, Erythrocyte Transfusion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.